Last update 09 May 2025

Universal NK cell(Jiangsu Provincial People's Hospital)

Overview

Basic Info

Drug Type
Natural Killer Cell Therapies
Synonyms
JY-306
Target
CD70
Action
modulators
Mechanism
CD70 modulators(CD70 antigen modulators)
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication
Recurrent Hematologic MalignancyRefractory Hematologic Malignancy
Inactive Indication-
Originator Organization
Jiangsu Provincial People's Hospital
Active Organization
Third Affiliated Hospital of Nanjing Medical UniversityThird Affiliated Hospital of Nanjing Medical University
Inactive Organization-
License Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Universal NK cell(Jiangsu Provincial People's Hospital)
NCT06837389
/ Not yet recruitingEarly Phase 1IIT
Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic Tumors
100 Clinical Results associated with Universal NK cell(Jiangsu Provincial People's Hospital)
Login to view more data
100 Translational Medicine associated with Universal NK cell(Jiangsu Provincial People's Hospital)
Login to view more data
100 Patents (Medical) associated with Universal NK cell(Jiangsu Provincial People's Hospital)
Login to view more data
100 Deals associated with Universal NK cell(Jiangsu Provincial People's Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Recurrent Hematologic MalignancyPhase 1-
Third Affiliated Hospital of Nanjing Medical UniversityThird Affiliated Hospital of Nanjing Medical University
15 Feb 2025
Refractory Hematologic MalignancyPhase 1-
Third Affiliated Hospital of Nanjing Medical UniversityThird Affiliated Hospital of Nanjing Medical University
15 Feb 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free